{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T04:56:20Z","timestamp":1782968180192,"version":"3.54.5"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T00:00:00Z","timestamp":1667520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T00:00:00Z","timestamp":1667520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100008386","name":"Marmara \u00dcniversitesi","doi-asserted-by":"publisher","award":["SAG-A-070617-0336"],"award-info":[{"award-number":["SAG-A-070617-0336"]}],"id":[{"id":"10.13039\/501100008386","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s11030-022-10551-0","type":"journal-article","created":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T16:03:44Z","timestamp":1667577824000},"page":"2185-2215","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Novel 1,2,4-triazoles derived from Ibuprofen: synthesis and in vitro evaluation of their mPGES-1 inhibitory and antiproliferative activity"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4219-4416","authenticated-orcid":false,"given":"Bahad\u0131r","family":"B\u00fclb\u00fcl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5216-669X","authenticated-orcid":false,"given":"Kai","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4128-7269","authenticated-orcid":false,"given":"Chang-Guo","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamze","family":"\u00c7ift\u00e7i","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0052-4926","authenticated-orcid":false,"given":"Kemal","family":"Yelek\u00e7i","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merve","family":"G\u00fcrbo\u011fa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0287-5639","authenticated-orcid":false,"given":"\u00d6zlem Bing\u00f6l","family":"\u00d6zakp\u0131nar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esra","family":"Aydemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz","family":"Bayba\u011f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fikrettin","family":"\u015eahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2273-5094","authenticated-orcid":false,"given":"Necla","family":"Kulaba\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8463-3571","authenticated-orcid":false,"given":"Sinem","family":"Helvac\u0131o\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4545-0756","authenticated-orcid":false,"given":"Mohammad","family":"Charehsaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3490-8597","authenticated-orcid":false,"given":"Esra","family":"Tatar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00fcheyla","family":"\u00d6zbey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7188-1859","authenticated-orcid":false,"given":"\u0130lkay","family":"K\u00fc\u00e7\u00fckg\u00fczel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,4]]},"reference":[{"key":"10551_CR1","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.2174\/1871520619666190227174137","volume":"19","author":"B B\u00fclb\u00fcl","year":"2019","unstructured":"B\u00fclb\u00fcl B, K\u00fc\u00e7\u00fckg\u00fczel \u0130 (2019) Microsomal prostaglandin E2 synthase-1 as a new macromolecular drug target in the prevention of inflammation and cancer. Anticancer Agents Med Chem 19:1205\u20131222. https:\/\/doi.org\/10.2174\/1871520619666190227174137","journal-title":"Anticancer Agents Med Chem"},{"key":"10551_CR2","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.prostaglandins.2015.06.002","volume":"120","author":"K Larsson","year":"2015","unstructured":"Larsson K, Jakobsson PJ (2015) Inhibition of microsomal prostaglandin E synthase-1 as targeted therapy in cancer treatment. Prostagland Other Lipid Mediat 120:161\u2013165. https:\/\/doi.org\/10.1016\/j.prostaglandins.2015.06.002","journal-title":"Prostagland Other Lipid Mediat"},{"key":"10551_CR3","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/S0006-291X(03)01079-9","volume":"306","author":"G Eibl","year":"2003","unstructured":"Eibl G, Bruemmer D, Okada Y, Duffy JP, Law RE, Reber HA, Hines OJ (2003) PGE2 is generated by specific COX-2 activity and increases VEGF production in COX-2-expressing human pancreatic cancer cells. Biochem Biophys Res Commun 306:887\u2013897. https:\/\/doi.org\/10.1016\/S0006-291X(03)01079-9","journal-title":"Biochem Biophys Res Commun"},{"key":"10551_CR4","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.bbrc.2014.08.032","volume":"451","author":"M Dufour","year":"2014","unstructured":"Dufour M, Faes S, Dormond-Meuwly A, Demartines N, Dormond O (2014) PGE2-induced colon cancer growth is mediated by MTORC1. Biochem Biophys Res Commun 451:587\u2013591. https:\/\/doi.org\/10.1016\/j.bbrc.2014.08.032","journal-title":"Biochem Biophys Res Commun"},{"key":"10551_CR5","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.toxlet.2013.12.014","volume":"225","author":"S Zhang","year":"2014","unstructured":"Zhang S, Da L, Yang X, Feng D, Yin R, Li M, Zhang Z, Jiang F, Xu L (2014) Celecoxib potentially inhibits metastasis of lung cancer promoted by surgery in mice, via suppression of the PGE2-modulated \u03b2-catenin pathway. Toxicol Lett 225:201\u2013207. https:\/\/doi.org\/10.1016\/j.toxlet.2013.12.014","journal-title":"Toxicol Lett"},{"key":"10551_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.prostaglandins.2011.08.005","volume":"96","author":"EP Chen","year":"2011","unstructured":"Chen EP, Smyth EM (2011) COX-2 and PGE2-dependent immunomodulation in breast cancer. Prostagland Other Lipid Mediat 96:14\u201320. https:\/\/doi.org\/10.1016\/j.prostaglandins.2011.08.005","journal-title":"Prostagland Other Lipid Mediat"},{"key":"10551_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.lfs.2014.07.042","volume":"116","author":"D Ruan","year":"2014","unstructured":"Ruan D, So SP (2014) Prostaglandin E2 produced by inducible COX-2 and MPGES-1 promoting cancer cell proliferation in vitro and in vivo. Life Sci 116:43\u201350. https:\/\/doi.org\/10.1016\/j.lfs.2014.07.042","journal-title":"Life Sci"},{"key":"10551_CR8","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.biochi.2010.02.006","volume":"92","author":"M Nakanishi","year":"2010","unstructured":"Nakanishi M, Gokhale V, Meuillet EJ, Rosenberg DW (2010) MPGES-1 as a target for cancer suppression. Biochimie 92:660\u2013664. https:\/\/doi.org\/10.1016\/j.biochi.2010.02.006","journal-title":"Biochimie"},{"key":"10551_CR9","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/j.1440-1789.2008.00963.x","volume":"29","author":"S Mattila","year":"2009","unstructured":"Mattila S, Tuominen H, Koivukangas J, Stenb\u00e4ck F (2009) The terminal prostaglandin synthases MPGES-1, MPGES-2, and CPGES are all overexpressed in human gliomas. Neuropathology 29:156\u2013165. https:\/\/doi.org\/10.1111\/j.1440-1789.2008.00963.x","journal-title":"Neuropathology"},{"key":"10551_CR10","doi-asserted-by":"publisher","first-page":"18757","DOI":"10.1073\/pnas.0910218106","volume":"106","author":"H Hanaka","year":"2009","unstructured":"Hanaka H, Pawelzik SC, Johnsen JI, Rakonjac M, Terawaki K, Rasmuson A, Sveinbj\u00f6rnsson B, Schumacher MC, Hamberg M, Samuelsson B, Jakobsson PJ, Kogner P, R\u00e5dmark O (2009) Microsomal prostaglandin E synthase 1 determines tumor growth in vivo of prostate and lung cancer cells. Proc Natl Acad Sci 106:18757\u201318762. https:\/\/doi.org\/10.1073\/pnas.0910218106","journal-title":"Proc Natl Acad Sci"},{"key":"10551_CR11","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.molmed.2012.02.002","volume":"18","author":"MD Salvado","year":"2012","unstructured":"Salvado MD, Alfranca A, Haeggstr\u00f6m JZ, Redondo JM (2012) Prostanoids in tumor angiogenesis: therapeutic intervention beyond COX-2. Trends Mol Med 18:233\u2013243. https:\/\/doi.org\/10.1016\/j.molmed.2012.02.002","journal-title":"Trends Mol Med"},{"key":"10551_CR12","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","volume":"31","author":"E Ricciotti","year":"2011","unstructured":"Ricciotti E, FitzGerald GA (2011) Prostaglandins and inflammation. Arterioscl Thromb Vasc Biol 31:986\u20131000. https:\/\/doi.org\/10.1161\/ATVBAHA.110.207449","journal-title":"Arterioscl Thromb Vasc Biol"},{"key":"10551_CR13","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ejmech.2018.09.007","volume":"158","author":"WM El-Husseiny","year":"2018","unstructured":"El-Husseiny WM, El-Sayed MAA, Abdel-Aziz NI, El-Azab AS, Asiri YA, Abdel-Aziz AAM (2018) Structural alterations based on naproxen scaffold: synthesis, evaluation of antitumor activity and COX-2 inhibition, and molecular docking. Eur J Med Chem 158:134\u2013143. https:\/\/doi.org\/10.1016\/j.ejmech.2018.09.007","journal-title":"Eur J Med Chem"},{"key":"10551_CR14","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1593\/neo.121890","volume":"15","author":"P Matos","year":"2013","unstructured":"Matos P, Kotelevets L, Jordan P, Gon\u00e7alves V, Henriques A, Zerbib P, Moyer MP, Chastre E (2013) Ibuprofen inhibits colitis-induced overexpression of tumorrelated Rac1b. Neoplasia 15:102\u2013111. https:\/\/doi.org\/10.1593\/neo.121890","journal-title":"Neoplasia"},{"key":"10551_CR15","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1158\/1940-6207.CAPR-10-0021","volume":"4","author":"EJ Greenspan","year":"2011","unstructured":"Greenspan EJ, Madigan JP, Boardman LA, Rosenberg DW (2011) Ibuprofen \u0131nhibits activation of nuclear \u03b2-catenin in human colon adenomas and \u0131nduces the phosphorylation of GSK-3\u03b2. Cancer Prev Res 4:161\u2013171. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-10-0021","journal-title":"Cancer Prev Res"},{"key":"10551_CR16","doi-asserted-by":"publisher","first-page":"e1027","DOI":"10.1038\/cddis.2013.550","volume":"5","author":"H Endo","year":"2014","unstructured":"Endo H, Yano M, Okumura Y, Kido H (2014) Ibuprofen enhances the anticancer activity of cisplatin in lung cancer cells by inhibiting the heat shock protein 70. Cell Death Dis 5:e1027\u2013e1027. https:\/\/doi.org\/10.1038\/cddis.2013.550","journal-title":"Cell Death Dis"},{"key":"10551_CR17","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.1016\/j.ejmech.2009.03.044","volume":"44","author":"KV Sujith","year":"2009","unstructured":"Sujith KV, Rao JN, Shetty P, Kalluraya B (2009) Regioselective reaction: synthesis and pharmacological study of mannich bases containing ibuprofen moiety. Eur J Med Chem 44:3697\u20133702. https:\/\/doi.org\/10.1016\/j.ejmech.2009.03.044","journal-title":"Eur J Med Chem"},{"key":"10551_CR18","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.ejmech.2009.10.031","volume":"45","author":"SE Abbas","year":"2010","unstructured":"Abbas SE, Awadallah FM, Ibrahim NA, Gouda AM (2010) Novel substituted and fused pyrrolizine derivatives: synthesis, anti-inflammatory and ulcerogenecity studies. Eur J Med Chem 45:482\u2013491. https:\/\/doi.org\/10.1016\/j.ejmech.2009.10.031","journal-title":"Eur J Med Chem"},{"key":"10551_CR19","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.farmac.2004.07.005","volume":"59","author":"\u0130 K\u00fc\u00e7\u00fckg\u00fczel","year":"2004","unstructured":"K\u00fc\u00e7\u00fckg\u00fczel \u0130, K\u00fc\u00e7\u00fckg\u00fczel \u015eG, Rollas S, \u00d6t\u00fck-San\u0131\u015f G, \u00d6zdemir O, Bayrak \u0130, Altu\u011f T, Stables JP (2004) Synthesis of some 3-(arylalkylthio)-4-alkyl\/aryl-5-(4-aminophenyl)-4H-1,2,4-triazole derivatives and their anticonvulsant activity. Il Farm 59:893\u2013901. https:\/\/doi.org\/10.1016\/j.farmac.2004.07.005","journal-title":"Il Farm"},{"key":"10551_CR20","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.ejmech.2007.04.010","volume":"43","author":"\u0130 K\u00fc\u00e7\u00fckg\u00fczel","year":"2008","unstructured":"K\u00fc\u00e7\u00fckg\u00fczel \u0130, Tatar E, K\u00fc\u00e7\u00fckg\u00fczel \u015eG, Rollas S, De Clercq E (2008) Synthesis of some novel thiourea derivatives obtained from 5-[(4-aminophenoxy)methyl]-4-alkyl\/aryl-2,4-dihydro-3h-1,2,4-triazole-3-thiones and evaluation as antiviral\/anti-HIV and anti-tuberculosis agents. Eur J Med Chem 43:381\u2013392. https:\/\/doi.org\/10.1016\/j.ejmech.2007.04.010","journal-title":"Eur J Med Chem"},{"key":"10551_CR21","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1016\/j.bmc.2005.11.029","volume":"14","author":"L Navidpour","year":"2006","unstructured":"Navidpour L, Shafaroodi H, Abdi K, Amini M, Ghahremani MH, Dehpour AR, Shafiee A (2006) Design, synthesis, and biological evaluation of substituted 3-alkylthio-4,5-diaryl-4H-1,2,4-triazoles as selective COX-2 inhibitors. Bioorg Med Chem 14:2507\u20132517. https:\/\/doi.org\/10.1016\/j.bmc.2005.11.029","journal-title":"Bioorg Med Chem"},{"key":"10551_CR22","doi-asserted-by":"publisher","first-page":"5738","DOI":"10.1016\/j.bmc.2007.06.006","volume":"15","author":"U Salg\u0131n-G\u00f6k\u015fen","year":"2007","unstructured":"Salg\u0131n-G\u00f6k\u015fen U, G\u00f6khan-Kelek\u00e7i N, G\u00f6kta\u015f \u00d6, K\u00f6ysal Y, K\u0131l\u0131\u00e7 E, I\u015f\u0131k \u015e, Aktay G, \u00d6zalp M (2007) 1-Acylthiosemicarbazides, 1,2,4-triazole-5(4H)-thiones, 1,3,4-thiadiazoles and hydrazones containing 5-methyl-2-benzoxazolinones: synthesis, analgesic-anti-inflammatory and antimicrobial activities. Bioorg Med Chem 15:5738\u20135751. https:\/\/doi.org\/10.1016\/j.bmc.2007.06.006","journal-title":"Bioorg Med Chem"},{"key":"10551_CR23","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.ejmech.2006.12.038","volume":"42","author":"\u015eG K\u00fc\u00e7\u00fckg\u00fczel","year":"2007","unstructured":"K\u00fc\u00e7\u00fckg\u00fczel \u015eG, K\u00fc\u00e7\u00fckg\u00fczel \u0130, Tatar E, Rollas S, \u015eahin F, G\u00fcll\u00fcce M, De Clercq E, Kabasakal L (2007) Synthesis of some novel heterocyclic compounds derived from diflunisal hydrazide as potential anti-infective and anti-inflammatory agents. Eur J Med Chem 42:893\u2013901. https:\/\/doi.org\/10.1016\/j.ejmech.2006.12.038","journal-title":"Eur J Med Chem"},{"key":"10551_CR24","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.bmcl.2007.12.025","volume":"18","author":"SM Sakya","year":"2008","unstructured":"Sakya SM, Shavnya A, Cheng H, Li C, Rast B, Li J, Koss DA, Jaynes BH, Mann DW, Petras CF, Seibel SB, Haven ML, Lynch MP (2008) comparative structure-activity relationship studies of 1-(5-methylsulfonylpyrid-2-Yl)-5-alkyl and (hetero)aryl triazoles and pyrazoles in canine COX inhibition. Bioorg Med Chem Lett 18:1042\u20131045. https:\/\/doi.org\/10.1016\/j.bmcl.2007.12.025","journal-title":"Bioorg Med Chem Lett"},{"key":"10551_CR25","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.4155\/fmc-2018-0467","volume":"11","author":"GS Hassan","year":"2019","unstructured":"Hassan GS, Hegazy GH, Ibrahim NM, Fahim SH (2019) New ibuprofen derivatives as H2S and NO donors as safer anti-inflammatory agents. Future Med Chem 11:3029\u20133045. https:\/\/doi.org\/10.4155\/fmc-2018-0467","journal-title":"Future Med Chem"},{"key":"10551_CR26","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ejmech.2016.05.017","volume":"121","author":"N Kulaba\u015f","year":"2016","unstructured":"Kulaba\u015f N, Tatar E, Bing\u00f6l \u00d6zakp\u0131nar \u00d6, \u00d6zsavc\u0131 D, Pannecouque C, De Clercq E, K\u00fc\u00e7\u00fckg\u00fczel \u0130 (2016) Synthesis and antiproliferative evaluation of novel 2-(4H\u20131,2,4-triazole-3-ylthio)acetamide derivatives as inducers of apoptosis in cancer cells. Eur J Med Chem 121:58\u201370. https:\/\/doi.org\/10.1016\/j.ejmech.2016.05.017","journal-title":"Eur J Med Chem"},{"key":"10551_CR27","first-page":"436","volume":"24","author":"G Erensoy","year":"2020","unstructured":"Erensoy G, Ding K, Zhan C-G, Elmezayen A, Yelek\u00e7i K (2020) Synthesis, in silico studies and cytotoxicity evaluation of novel 1,3,4-oxadiazole derivatives designed as potential MPGES-1 \u0131nhibitors. J Res Pharm 24:436\u2013451","journal-title":"J Res Pharm"},{"key":"10551_CR28","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s11030-020-10131-0","volume":"25","author":"A Turky","year":"2021","unstructured":"Turky A, Bayoumi AH, Sherbiny FF, El-Adl K, Abulkhair HS (2021) Unravelling the anticancer potency of 1,2,4-triazole-N-arylamide hybrids through Inhibition of STAT3: synthesis and in silico mechanistic studies. Mol Divers 25:403\u2013420. https:\/\/doi.org\/10.1007\/s11030-020-10131-0","journal-title":"Mol Divers"},{"key":"10551_CR29","doi-asserted-by":"publisher","first-page":"e2000170","DOI":"10.1002\/ardp.202000170","volume":"353","author":"A Turky","year":"2020","unstructured":"Turky A, Sherbiny FF, Bayoumi AH, Ahmed HEA, Abulkhair HS (2020) Novel 1,2,4-triazole derivatives: design, synthesis, anticancer evaluation, molecular docking, and pharmacokinetic profiling studies. Arch Pharm (Weinheim) 353:e2000170. https:\/\/doi.org\/10.1002\/ardp.202000170","journal-title":"Arch Pharm (Weinheim)"},{"key":"10551_CR30","doi-asserted-by":"publisher","first-page":"3296","DOI":"10.1021\/jm301900x","volume":"56","author":"S He","year":"2013","unstructured":"He S, Li C, Liu Y, Lai L (2013) Discovery of highly potent microsomal prostaglandin E 2 synthase 1 inhibitors using the active conformation structural model and virtual screen. J Med Chem 56:3296\u20133309. https:\/\/doi.org\/10.1021\/jm301900x","journal-title":"J Med Chem"},{"key":"10551_CR31","first-page":"532","volume":"117","author":"I Vasincu","year":"2013","unstructured":"Vasincu I, Apotrosoaei M, Tuchilu\u015f C, P\u00e2nzariu AT, Dragostin O, Lupa\u015fcu D (2013) Profire, L new der\u0131vat\u0131ves of aryl-prop\u0131on\u0131c ac\u0131d. Synthes\u0131s and b\u0131olog\u0131cal evaluat\u0131on. Rev Med Chir Soc Med Nat Ia\u015fi 117:532\u2013537","journal-title":"Rev Med Chir Soc Med Nat Ia\u015fi"},{"key":"10551_CR32","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1002\/jhet.3357","volume":"55","author":"E Dhall","year":"2018","unstructured":"Dhall E, Jain S, Mishra A, Dwivedi J, Sharma S (2018) Synthesis and evaluation of some phenyl substituted azetidine containing 1, 2, 4-triazole derivatives as antibacterial agents. J Heterocycl Chem 55:2859\u20132869. https:\/\/doi.org\/10.1002\/jhet.3357","journal-title":"J Heterocycl Chem"},{"key":"10551_CR33","first-page":"96","volume":"4","author":"K Raviprabha","year":"2015","unstructured":"Raviprabha K, Manjunatha K, Poojary B, Kumar V, Harish N (2015) Synthesis, characterisation and antimicrobial activities of newer 3,4,5-trisubstitued [1,2,4]-triazoles derivatives. Int J Pharm Res Sch 4:96\u2013104","journal-title":"Int J Pharm Res Sch"},{"key":"10551_CR34","first-page":"207","volume":"7","author":"K Manjunatha","year":"2015","unstructured":"Manjunatha K, Poojary B, Kumar V, Lobo PL, Fernandes J, Chandrashekhar C (2015) Synthesis, characterization and antimicrobial activities of imidazo-[2,1, b][1,3,4]-thiadiazoles. Pharma Chem 7:207\u2013215","journal-title":"Pharma Chem"},{"key":"10551_CR35","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/jps.2600830226","volume":"83","author":"LVG Nargund","year":"1994","unstructured":"Nargund LVG, Reddy GRN, Hariprasad V (1994) Anti-inflammatory activity of substituted 1,3,4-oxadiazoles. J Pharm Sci 83:246\u2013248. https:\/\/doi.org\/10.1002\/jps.2600830226","journal-title":"J Pharm Sci"},{"key":"10551_CR36","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1515\/DMDI.1995.12.2.145","volume":"12","author":"BB Durgun","year":"1995","unstructured":"Durgun BB, Rollas S, Apayd\u0131n S, \u00d6zt\u00fcrk R (1995) Synthesis and antimicrobial activity of some new 1-[4-(4-fluorobenzoylamino) benzoyl)-4-substituted thiosemicarbazides. Drug Metabol Drug Interact 12:145. https:\/\/doi.org\/10.1515\/DMDI.1995.12.2.145","journal-title":"Drug Metabol Drug Interact"},{"key":"10551_CR37","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1515\/DMDI.1999.15.2-3.187","volume":"15","author":"H Do\u011fan","year":"1999","unstructured":"Do\u011fan H, Duran A, Yemni E (1999) Synthes\u0131s and ant\u0131bacter\u0131al act\u0131v\u0131ty of l-(3-hydroxy-2-naphthoyl)-4-subst\u0131tuted th\u0131osem\u0131carbaz\u0131des. Drug Metabol Drug Interact 15:10","journal-title":"Drug Metabol Drug Interact"},{"key":"10551_CR38","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0223-5234(01)01326-5","volume":"37","author":"\u015eG K\u00fc\u00e7\u00fckg\u00fczel","year":"2002","unstructured":"K\u00fc\u00e7\u00fckg\u00fczel \u015eG, Oru\u00e7 EE, Rollas S, \u015eahin F, \u00d6zbek A (2002) Synthesis, characterisation and biological activity of novel 4-thiazolidinones, 1,3,4-oxadiazoles and some related compounds. Eur J Med Chem 37:197\u2013206. https:\/\/doi.org\/10.1016\/S0223-5234(01)01326-5","journal-title":"Eur J Med Chem"},{"key":"10551_CR39","first-page":"23","volume":"44","author":"N Cesur","year":"2002","unstructured":"Cesur N, Birteks\u00f6z S, \u00d6t\u00fck G (2002) Synthesis and biological evulation of some new thiosemicarbazides, 4-thiazolidinone, 1,3,4-oxadiazole and 1,2,4-triazole-3-thione derivatives bearing imidazo[1,2-\u03b1]pyridine moiety. Acta Pharm Turc 44:23\u201341","journal-title":"Acta Pharm Turc"},{"key":"10551_CR40","doi-asserted-by":"publisher","first-page":"56","DOI":"10.12991\/201216421","volume":"1","author":"I \u00c7oruh","year":"2012","unstructured":"\u00c7oruh I, Rollas S, Turan S, Akbu\u011fa J (2012) Synthesis and evaluation of cytotoxic activities of some 1,4-disubstituted thiosemicarbazides, 2,5-disubstituted-1,3,4-thiadiazoles and 1,2,4-triazole-5-thiones derived from benzilic acid hydrazide. Marmara Pharm J 1:56\u201363","journal-title":"Marmara Pharm J"},{"key":"10551_CR41","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/0223-5234(96)83976-6","volume":"31","author":"F Omar","year":"1996","unstructured":"Omar F, Mahfouz N, Rahman M (1996) Design, synthesis and antiinflammatory activity of some 1,3,4-oxadiazole derivatives. Eur J Med Chem 31:819\u2013825. https:\/\/doi.org\/10.1016\/0223-5234(96)83976-6","journal-title":"Eur J Med Chem"},{"key":"10551_CR42","first-page":"155","volume":"24","author":"M Tutoveanu","year":"1973","unstructured":"Tutoveanu M, Constantinescu C, Maerean V (1973) New semi- and thiosemicarbazides and cyclization products. Rev Chim 24:155\u2013158","journal-title":"Rev Chim"},{"key":"10551_CR43","first-page":"101","volume":"44","author":"G Vasilev","year":"1991","unstructured":"Vasilev G (1991) Synthesis and growth-regulating activity of some hydrazides and thiosemicarbazides of the benzoic, phenylacetic, and 1-naphthylacetic acids. Dokl Na Bulg Akad Na Nauk 44:101\u2013104","journal-title":"Dokl Na Bulg Akad Na Nauk"},{"key":"10551_CR44","first-page":"123","volume":"53","author":"M Dobosz","year":"1996","unstructured":"Dobosz M, Pachuta-Stec A (1996) Synthesis of new derivatives of 3-benzyl-\u03b42-1,2,4-triazoline-5thione and 5-benzyl-1,3,4-thiadiazole. Act Pol Pharm Drug Res 53:123\u2013131","journal-title":"Act Pol Pharm Drug Res"},{"key":"10551_CR45","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1080\/10426507.2012.757612","volume":"188","author":"M Wujec","year":"2013","unstructured":"Wujec M, Pachuta-Stec A, Stefa\u0144ska J, Ku\u015bmierz E, Siwek A (2013) Synthesis and antibacterial activity of some new derivatives of thiosemicarbazide and 1,2,4-triazole. Phosph Sulfur Silicon Relat Elem 188:1661\u20131669. https:\/\/doi.org\/10.1080\/10426507.2012.757612","journal-title":"Phosph Sulfur Silicon Relat Elem"},{"key":"10551_CR46","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.ejmech.2014.11.033","volume":"97","author":"\u015eG K\u00fc\u00e7\u00fckg\u00fczel","year":"2015","unstructured":"K\u00fc\u00e7\u00fckg\u00fczel \u015eG, \u00c7\u0131kla-S\u00fczg\u00fcn P (2015) Recent advances bioactive 1,2,4-triazole-3-thiones. Eur J Med Chem 97:830\u2013870. https:\/\/doi.org\/10.1016\/j.ejmech.2014.11.033","journal-title":"Eur J Med Chem"},{"key":"10551_CR47","first-page":"5","volume":"40","author":"N Ulusoy","year":"1998","unstructured":"Ulusoy N, \u00c7apan G, Ergen\u00e7 N, Ekinci A, Vidin A (1998) Synthesis, characterization and anticonvulsant activity of new 4-thiazolidinone and 1,2,4-triazole-3-thione derivatives. Acta Pharm Turc 40:5\u20138","journal-title":"Acta Pharm Turc"},{"key":"10551_CR48","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.3390\/molecules23081969","volume":"23","author":"G Co\u015fkun","year":"2018","unstructured":"Co\u015fkun G, Djikic T, Hayal T, T\u00fcrkel N, Yelek\u00e7i K, \u015eahin F, K\u00fc\u00e7\u00fckg\u00fczel \u015e (2018) Synthesis, molecular docking and anticancer activity of diflunisal derivatives as cyclooxygenase enzyme inhibitors. Molecules 23:1969. https:\/\/doi.org\/10.3390\/molecules23081969","journal-title":"Molecules"},{"key":"10551_CR49","unstructured":"Marcel P, Bellon R (1961) Erfectionnements Au Proc\u00e9d\u00e9 de Pr\u00e9paration Des Mercapto 3 Triazoles 1. 2. 4. Etproduits Fabriqu\u00e9s Selon Le Proc\u00e9d\u00e9. FR1273881(A) 1961-10-20."},{"key":"10551_CR50","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.1016\/j.bmc.2013.04.022","volume":"21","author":"M Abdel-Aziz","year":"2013","unstructured":"Abdel-Aziz M, Abuo-Rahma GEDAA, Beshr EAM, Ali TFS (2013) New nitric oxide donating 1,2,4-triazole\/oxime hybrids: synthesis, investigation of anti-inflammatory, ulceroginic liability and antiproliferative activities. Bioorg Med Chem 21:3839\u20133849. https:\/\/doi.org\/10.1016\/j.bmc.2013.04.022","journal-title":"Bioorg Med Chem"},{"key":"10551_CR51","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.bioorg.2017.09.018","volume":"75","author":"AM Mohassab","year":"2017","unstructured":"Mohassab AM, Hassan HA, Abdelhamid D, Abdel-Aziz M, Dalby KN, Kaoud TS (2017) Novel quinoline incorporating 1,2,4-triazole\/oxime hybrids: synthesis, molecular docking, anti-inflammatory, cox inhibition, ulceroginicity and histopathological investigations. Bioorg Chem 75:242\u2013259. https:\/\/doi.org\/10.1016\/j.bioorg.2017.09.018","journal-title":"Bioorg Chem"},{"key":"10551_CR52","first-page":"143","volume":"24","author":"A Karakurt","year":"1999","unstructured":"Karakurt A, Dalkara S (1999) Oksim ve Oksim Eterler: I. Sentezleri ve Farmakolojik \u00d6zellikleri. FABAD J Pharm Sci 24:143\u2013156","journal-title":"FABAD J Pharm Sci"},{"issue":"308","key":"10551_CR53","first-page":"309","volume":"48","author":"S Rollas","year":"1993","unstructured":"Rollas S, Kalyoncuo\u011flu N, Alt\u0131ner D, Ye\u011feno\u011flu Y (1993) 5-(4-Aminophenyl)-4-substitued 2,4-dihydro-3H-1,2,4-triazole-3-thiones: synthesis and antibacterial and antifungal activities. Pharmazie 48(308):309","journal-title":"Pharmazie"},{"key":"10551_CR54","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.ejmech.2008.06.019","volume":"44","author":"H Bayrak","year":"2009","unstructured":"Bayrak H, Demirbas A, Karaoglu SA, Demirbas N (2009) Synthesis of some new 1,2,4-triazoles, their Mannich and Schiff bases and evaluation of their antimicrobial activities. Eur J Med Chem 44:1057\u20131066. https:\/\/doi.org\/10.1016\/j.ejmech.2008.06.019","journal-title":"Eur J Med Chem"},{"key":"10551_CR55","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1016\/j.ejmech.2008.01.039","volume":"43","author":"H Kumar","year":"2008","unstructured":"Kumar H, Javed SA, Khan SA, Amir M (2008) 1,3,4-Oxadiazole\/thiadiazole and 1,2,4-triazole derivatives of biphenyl-4-yloxy acetic acid: synthesis and preliminary evaluation of biological properties. Eur J Med Chem 43:2688\u20132698. https:\/\/doi.org\/10.1016\/j.ejmech.2008.01.039","journal-title":"Eur J Med Chem"},{"key":"10551_CR56","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2478\/v10007-007-0003-y","volume":"57","author":"M Amir","year":"2007","unstructured":"Amir M, Kumar S (2007) Synthesis and evaluation of anti-inflammatory, analgesic, ulcerogenic and lipid peroxidation properties of ibuprofen derivatives. Acta Pharm 57:31\u201345. https:\/\/doi.org\/10.2478\/v10007-007-0003-y","journal-title":"Acta Pharm"},{"key":"10551_CR57","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/0223-5234(96)88277-8","volume":"30","author":"H Baji","year":"1995","unstructured":"Baji H, Flammang M, Kimny T, Gasquez F, Compagnon P, Delcourt A (1995) Synthesis and antifungal activity of novel (l-aryl-2-heterocyclyl)ethylideneaminooxymethyl-substituted dioxolanes. Eur J Med Chem 30:617\u2013626","journal-title":"Eur J Med Chem"},{"key":"10551_CR58","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/S1386-1425(99)00266-8","volume":"56","author":"MS Ansari","year":"2000","unstructured":"Ansari MS, Rama NH, Hussain MT, Raza AR (2000) Diastereotopy in some 3,4-dihydroisocoumarins\u2014effect of changing the substituents on the chiral centre. Spectrochim Acta A Mol Biomol Spectrosc 56:1385\u20131389. https:\/\/doi.org\/10.1016\/S1386-1425(99)00266-8","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"10551_CR59","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1016\/S1386-1425(01)00698-9","volume":"58","author":"N Khan","year":"2002","unstructured":"Khan N, Ansari MS, Baber Z (2002) Diastereotopic effect in some N-Substituted-3-methyl-4,1-benzoxazepine-2,5-diones. Spectrochim Acta A Mol Biomol Spectrosc 58:2265\u20132269. https:\/\/doi.org\/10.1016\/S1386-1425(01)00698-9","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"10551_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/14756366.2015.1039531","volume":"31","author":"T Fr\u0105czek","year":"2015","unstructured":"Fr\u0105czek T, Paneth A, Kami\u0144ski R, Krakowiak A, Paneth P (2015) Searching for novel scaffold of triazole non-nucleoside inhibitors of HIV-1 reverse transcriptase. J Enzyme Inhib Med Chem 31:1\u20139. https:\/\/doi.org\/10.3109\/14756366.2015.1039531","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10551_CR61","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.xphs.2021.10.011","volume":"111","author":"C Saal","year":"2021","unstructured":"Saal C, Becker A, Krier M, Fuch\u00df T (2021) Atropisomerism: a neglected way to escape out of solubility flatlands. J Pharm Sci 111:206\u2013213. https:\/\/doi.org\/10.1016\/j.xphs.2021.10.011","journal-title":"J Pharm Sci"},{"key":"10551_CR62","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/chir.23306","volume":"33","author":"A Laoufi","year":"2021","unstructured":"Laoufi A, Belboukhari N, Sekkoum K, Aboul-Enein HY (2021) Synthesis and chiral separation of atropisomers of 4,5-di methyl \u2206 4 N-phenyl N-aryl Imidazoline-2-thione derivatives. Chirality 33:264\u2013273. https:\/\/doi.org\/10.1002\/chir.23306","journal-title":"Chirality"},{"key":"10551_CR63","first-page":"171","volume-title":"In Spectrometric identification of organic compounds","author":"R Silverstein","year":"2005","unstructured":"Silverstein R, Webster F, Kiemle J (2005) In Spectrometric identification of organic compounds. Wiley, New Jersey, pp 171\u2013172"},{"key":"10551_CR64","volume-title":"Basic 1 H- and 13 C-NMR spectroscopy, 1 edn, transferred to digital print","author":"M Balc\u0131","year":"2005","unstructured":"Balc\u0131 M (2005) Basic 1 H- and 13 C-NMR spectroscopy, 1 edn, transferred to digital print. Elsevier, Amsterdam, Heidelberg"},{"key":"10551_CR65","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/S0014-827X(99)00109-3","volume":"54","author":"NS G\u00fcnay","year":"1999","unstructured":"G\u00fcnay NS, \u00c7apan G, Ulusoy N, Ergen\u00e7 N, \u00d6t\u00fck G, Kaya D (1999) 5-Nitroimidazole derivatives as possible antibacterial and antifungal agents. Il Farm 54:826\u2013831. https:\/\/doi.org\/10.1016\/S0014-827X(99)00109-3","journal-title":"Il Farm"},{"key":"10551_CR66","doi-asserted-by":"publisher","first-page":"o155","DOI":"10.1107\/S1600536812051276","volume":"69","author":"Z Karczmarzyk","year":"2013","unstructured":"Karczmarzyk Z, Pitucha M, Wysocki W, Pachuta-Stec A, Sta\u0144czuk A (2013) 3-Benzyl-4-ethyl-1 H-1,2,4-triazole-5(4 H )-thione. Acta Crystallogr Sect E Struct Rep Online 69:o155\u2013o156. https:\/\/doi.org\/10.1107\/S1600536812051276","journal-title":"Acta Crystallogr Sect E Struct Rep Online"},{"key":"10551_CR67","unstructured":"Andersen HKG, Christensen I, Mogensen J, Larsen (2004) Pharmaceutical use of substituted 1,2,4-triazoles. WO2004\/089367(A1)."},{"key":"10551_CR68","unstructured":"Kampen G, Andersen H (2004) Combination therapy using an 11-beta-hydroxysteroid dehydrogenase type 1 \u0131nhibitor and an antihypertansive agent for the treatment of metabolic syndrome and related diseases and disorders. Patent No: WO2004\/089416(A2)."},{"key":"10551_CR69","unstructured":"Kampen G Andersen H (2004) Combination therapy using an 11\u03b2-hydroxysteroid dehydrogenase type 1 \u0131nhibitor and a glucocorticoid receptor agonist to minimize the side effects associated with glucocorticoid receptor agonist therapy. WO2004\/089415(A2)"},{"key":"10551_CR70","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.bcp.2008.04.008","volume":"76","author":"I Wobst","year":"2008","unstructured":"Wobst I, Schiffmann S, Birod K, Maier TJ, Schmidt R, Angioni C, Geisslinger G, Gr\u00f6sch S (2008) Dimethylcelecoxib inhibits prostaglandin E2 production. Biochem Pharmacol 76:62\u201369. https:\/\/doi.org\/10.1016\/j.bcp.2008.04.008","journal-title":"Biochem Pharmacol"},{"key":"10551_CR71","doi-asserted-by":"publisher","first-page":"7874","DOI":"10.1016\/j.bmc.2013.10.006","volume":"21","author":"T Hanke","year":"2013","unstructured":"Hanke T, R\u00f6rsch F, Thieme TM, Ferreiros N, Schneider G, Geisslinger G, Proschak E, Gr\u00f6sch S, Schubert-Zsilavecz M (2013) Synthesis and pharmacological characterization of benzenesulfonamides as dual species inhibitors of human and murine MPGES-1. Bioorg Med Chem 21:7874\u20137883. https:\/\/doi.org\/10.1016\/j.bmc.2013.10.006","journal-title":"Bioorg Med Chem"},{"key":"10551_CR72","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.prostaglandins.2013.04.002","volume":"106","author":"LR Howe","year":"2013","unstructured":"Howe LR, Subbaramaiah K, Kent CV, Zhou XK, Chang S-H, Hla T, Jakobsson P-J, Hudis CA, Dannenberg AJ (2013) Genetic deletion of microsomal prostaglandin E synthase-1 suppresses mouse mammary tumor growth and angiogenesis. Prostaglandins Other Lipid Mediat 106:99\u2013105. https:\/\/doi.org\/10.1016\/j.prostaglandins.2013.04.002","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10551_CR73","doi-asserted-by":"publisher","first-page":"10284","DOI":"10.18632\/oncotarget.3581","volume":"6","author":"C Olesch","year":"2015","unstructured":"Olesch C, Sha W, Angioni C, Sha LK, A\u00e7af E, Patrignani P, Jakobsson P-J, Radeke HH, Gr\u00f6sch S, Geisslinger G, von Knethen A, Weigert A, Br\u00fcne B (2015) MPGES-1-derived PGE2 suppresses CD80 expression on tumor-associated phagocytes to \u0131nhibit anti-tumor \u0131mmune responses in breast cancer. Oncotarget 6:10284\u201310296","journal-title":"Oncotarget"},{"key":"10551_CR74","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.3892\/etm.2018.6538","volume":"16","author":"Y Li","year":"2018","unstructured":"Li Y, Chen J, Yin S, Nie D, He Z, Xie S, Wang X, Wu Y, Xiao J, Liu H, Wang J, Yang W, Ma L (2018) Regulation of MPGES-1 composition and cell growth via the MAPK signaling pathway in jurkat cells. Exp Ther Med 16:3211\u20133219. https:\/\/doi.org\/10.3892\/etm.2018.6538","journal-title":"Exp Ther Med"},{"key":"10551_CR75","doi-asserted-by":"publisher","first-page":"105968","DOI":"10.1016\/j.bioorg.2022.105968","volume":"127","author":"EM Othman","year":"2022","unstructured":"Othman EM, Fayed EA, Husseiny EM, Abulkhair HS (2022) The effect of novel synthetic semicarbazone- and thiosemicarbazone-linked 1,2,3-triazoles on the apoptotic markers, VEGFR-2, and cell cycle of myeloid leukemia. Bioorganic Chem 127:105968. https:\/\/doi.org\/10.1016\/j.bioorg.2022.105968","journal-title":"Bioorganic Chem"},{"key":"10551_CR76","doi-asserted-by":"publisher","first-page":"105762","DOI":"10.1016\/j.bioorg.2022.105762","volume":"123","author":"EM Othman","year":"2022","unstructured":"Othman EM, Fayed EA, Husseiny EM, Abulkhair HS (2022) Apoptosis induction, PARP-1 inhibition, and cell cycle analysis of leukemia cancer cells treated with novel synthetic 1,2,3-triazole\u2013chalcone conjugates. Bioorg Chem 123:105762. https:\/\/doi.org\/10.1016\/j.bioorg.2022.105762","journal-title":"Bioorg Chem"},{"key":"10551_CR77","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1227\/NEU.0b013e318210f258","volume":"68","author":"D \u00d6zsavc\u00ed","year":"2011","unstructured":"\u00d6zsavc\u00ed D, Er\u015fahin M, \u015eener A, \u00d6zakpinar \u00d6B, Toklu HZ, Akak\u00edn D, \u015eener G, Ye\u011fen B\u00c7 (2011) The novel function of nesfatin-1 as an anti-inflammatory and antiapoptotic peptide in subarachnoid hemorrhage-induced oxidative brain damage in rats. Neurosurgery 68:1699\u20131708. https:\/\/doi.org\/10.1227\/NEU.0b013e318210f258","journal-title":"Neurosurgery"},{"key":"10551_CR78","doi-asserted-by":"publisher","first-page":"5205","DOI":"10.1038\/s41598-018-23482-4","volume":"8","author":"K Ding","year":"2018","unstructured":"Ding K, Zhou Z, Hou S, Yuan Y, Zhou S, Zheng X, Chen J, Loftin C, Zheng F, Zhan C-G (2018) Structure-based discovery of MPGES-1 \u0131nhibitors suitable for preclinical testing in wild-type mice as a new generation of anti-\u0131nflammatory drugs. Sci Rep 8:5205. https:\/\/doi.org\/10.1038\/s41598-018-23482-4","journal-title":"Sci Rep"},{"key":"10551_CR79","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1083\/jcb.107.4.1589","volume":"107","author":"Y Kubota","year":"1988","unstructured":"Kubota Y, Kleinman HK, Martin GR, Lawley TJ (1988) Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures. J Cell Biol 107:1589\u20131598. https:\/\/doi.org\/10.1083\/jcb.107.4.1589","journal-title":"J Cell Biol"},{"key":"10551_CR80","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1042\/BJ20090045","volume":"425","author":"D Kamei","year":"2010","unstructured":"Kamei D, Murakami M, Sasaki Y, Nakatani Y, Majima M, Ishikawa Y, Ishii T, Uematsu S, Akira S, Hara S, Kudo I (2010) Microsomal prostaglandin E synthase-1 in both cancer cells and hosts contributes to tumour growth, invasion and metastasis. Biochem J 425:361\u2013371. https:\/\/doi.org\/10.1042\/BJ20090045","journal-title":"Biochem J"},{"key":"10551_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yrtph.2009.09.012","volume":"56","author":"K-M Wu","year":"2010","unstructured":"Wu K-M, Dou J, Ghantous H, Chen S, Bigger A, Birnkrant D (2010) Current regulatory perspectives on genotoxicity testing for botanical drug product development in the U.S.A. Regul Toxicol Pharmacol 56:1\u20133. https:\/\/doi.org\/10.1016\/j.yrtph.2009.09.012","journal-title":"Regul Toxicol Pharmacol"},{"key":"10551_CR82","doi-asserted-by":"publisher","first-page":"28343","DOI":"10.1039\/C5RA25186A","volume":"6","author":"P Khurana","year":"2016","unstructured":"Khurana P, Jachak SM (2016) Chemistry and biology of microsomal prostaglandin E 2 synthase-1 (MPGES-1) inhibitors as novel anti-inflammatory agents: recent developments and current status. RSC Adv 6:28343\u201328369. https:\/\/doi.org\/10.1039\/C5RA25186A","journal-title":"RSC Adv"},{"key":"10551_CR83","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1139\/v90-227","volume":"68","author":"S Stoyanov","year":"1990","unstructured":"Stoyanov S, Petkov I, Antonov L, Stoyanova T, Karagiannidis P, Aslanidis P (1990) Thione-thiol tautomerism and stability of 2- and 4-mercaptopyridines and 2-mercaptopyrimidines. Can J Chem 68:1482\u20131489. https:\/\/doi.org\/10.1139\/v90-227","journal-title":"Can J Chem"},{"key":"10551_CR84","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46:3\u201326","journal-title":"Adv Drug Deliv Rev"},{"key":"10551_CR85","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1021\/jm020017n","volume":"45","author":"DF Veber","year":"2002","unstructured":"Veber DF, Johnson SR, Cheng H-Y, Smith BR, Ward KW, Kopple KD (2002) Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem 45:2615\u20132623. https:\/\/doi.org\/10.1021\/jm020017n","journal-title":"J Med Chem"},{"key":"10551_CR86","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/cmdc.201600182","volume":"11","author":"A Daina","year":"2016","unstructured":"Daina A, Zoete VA (2016) BOILED-egg to predict gastrointestinal absorption and brain penetration of small molecules. Chem Med Chem 11:1117\u20131121. https:\/\/doi.org\/10.1002\/cmdc.201600182","journal-title":"Chem Med Chem"},{"key":"10551_CR87","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2165\/00003088-200342010-00003","volume":"42","author":"JH Lin","year":"2003","unstructured":"Lin JH, Yamazaki M (2003) Role of P-glycoprotein in pharmacokinetics: clinical implications. Clin Pharmacokinet 42:59\u201398. https:\/\/doi.org\/10.2165\/00003088-200342010-00003","journal-title":"Clin Pharmacokinet"},{"key":"10551_CR88","doi-asserted-by":"publisher","first-page":"5605","DOI":"10.1021\/jp100668y","volume":"114","author":"A Hamza","year":"2010","unstructured":"Hamza A, Tong M, AbdulHameed MDM, Liu J, Goren AC, Tai H-H, Zhan C-G (2010) Understanding microscopic binding of human microsomal prostaglandin E synthase-1 (MPGES-1) trimer with substrate PGH 2 and cofactor GSH: insights from computational alanine scanning and site-directed mutagenesis. J Phys Chem B 114:5605\u20135616. https:\/\/doi.org\/10.1021\/jp100668y","journal-title":"J Phys Chem B"},{"key":"10551_CR89","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.bmcl.2018.02.011","volume":"28","author":"K Ding","year":"2018","unstructured":"Ding K, Zhou Z, Zhou S, Yuan Y, Kim K, Zhang T, Zheng X, Zheng F, Zhan C-G (2018) Design, synthesis, and discovery of 5-((1,3-diphenyl-1 H-pyrazol-4-Yl)methylene)pyrimidine-2,4,6(1 H,3 H,5 H)-triones and related derivatives as novel inhibitors of MPGES-1. Bioorg Med Chem Lett 28:858\u2013862. https:\/\/doi.org\/10.1016\/j.bmcl.2018.02.011","journal-title":"Bioorg Med Chem Lett"},{"key":"10551_CR90","doi-asserted-by":"publisher","first-page":"6077","DOI":"10.1016\/j.bmc.2011.08.040","volume":"19","author":"A Hamza","year":"2011","unstructured":"Hamza A, Zhao X, Tong M, Tai H-H, Zhan C-G (2011) Novel human MPGES-1 inhibitors identified through structure-based virtual screening. Bioorg Med Chem 19:6077\u20136086. https:\/\/doi.org\/10.1016\/j.bmc.2011.08.040","journal-title":"Bioorg Med Chem"},{"key":"10551_CR91","doi-asserted-by":"publisher","first-page":"3739","DOI":"10.1016\/j.bmcl.2017.06.075","volume":"27","author":"Z Zhou","year":"2017","unstructured":"Zhou Z, Yuan Y, Zhou S, Ding K, Zheng F, Zhan C-G (2017) Selective inhibitors of human MPGES-1 from structure-based computational screening. Bioorg Med Chem Lett 27:3739\u20133743. https:\/\/doi.org\/10.1016\/j.bmcl.2017.06.075","journal-title":"Bioorg Med Chem Lett"},{"key":"10551_CR92","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/0167-4889(95)00144-1","volume":"1310","author":"L Harding","year":"1996","unstructured":"Harding L, Wang Z, Tai H-H (1996) Stimulation of prostaglandin E2 synthesis by interleukin-1\/3 is amplified by interferons but inhibited by interleukin-4 in human amnion-derived wish cells. Biochim Biophys Acta 1310:48\u201352","journal-title":"Biochim Biophys Acta"},{"key":"10551_CR93","volume-title":"471: Bacterial reverse mutation test, in OECD guidelines for the testing of chemicals","author":"T No","year":"2020","unstructured":"No T (2020) 471: Bacterial reverse mutation test, in OECD guidelines for the testing of chemicals. OECD Publishing, Paris"},{"key":"10551_CR94","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/0165-1161(83)90010-9","volume":"113","author":"DM Maron","year":"1983","unstructured":"Maron DM, Ames BN (1983) Revised methods for the salmonella mutagenicity test. Mutat Res 113:173\u2013215","journal-title":"Mutat Res"},{"key":"10551_CR95","doi-asserted-by":"publisher","first-page":"4824","DOI":"10.1016\/j.bmcl.2016.08.023","volume":"26","author":"SL Kuklish","year":"2016","unstructured":"Kuklish SL, Antonysamy S, Bhattachar SN, Chandrasekhar S, Fisher MJ, Fretland AJ, Gooding K, Harvey A, Hughes NE, Luz JG, Manninen PR, McGee JE, Navarro A, Norman BH, Partridge KM, Quimby SJ, Schiffler MA, Sloan AV, Warshawsky AM, York JS, Yu XP (2016) Characterization of 3,3-dimethyl substituted N-aryl piperidines as potent microsomal prostaglandin E synthase-1 inhibitors. Bioorg Med Chem Lett 26:4824\u20134828. https:\/\/doi.org\/10.1016\/j.bmcl.2016.08.023","journal-title":"Bioorg Med Chem Lett"},{"key":"10551_CR96","doi-asserted-by":"publisher","unstructured":"Cingolani G, Panella A, Perrone MG, Vitale P, di Mauro G, Fortuna CG, Armen RS, Ferorelli S, Smith WL, Scilimati A (2017) Structural basis for selective \u0131nhibition of cyclooxygenase-1 (COX-1) by diarylisoxazoles mofezolac and 3-(5-chlorofuran-2-Yl)-5-methyl-4-phenylisoxazole (P6). Eur J Med Chem 138:661\u2013668. https:\/\/doi.org\/10.1016\/j.ejmech.2017.06.045","DOI":"10.1016\/j.ejmech.2017.06.045"},{"key":"10551_CR97","doi-asserted-by":"publisher","first-page":"34950","DOI":"10.1074\/jbc.M110.162982","volume":"285","author":"KC Duggan","year":"2010","unstructured":"Duggan KC, Walters MJ, Musee J, Harp JM, Kiefer JR, Oates JA, Marnett LJ (2010) Molecular basis for cyclooxygenase inhibition by the non-steroidal anti-inflammatory drug naproxen. J Biol Chem 285:34950\u201334959. https:\/\/doi.org\/10.1074\/jbc.M110.162982","journal-title":"J Biol Chem"},{"key":"10551_CR98","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30:2785\u20132791. https:\/\/doi.org\/10.1002\/jcc.21256","journal-title":"J Comput Chem"},{"key":"10551_CR99","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","volume":"19","author":"G Morris","year":"1998","unstructured":"Morris G, Goodsell D, Halliday R, Huey R, Hart W, Belew Olson A (1998) Automated docking using a lamarckian genetic algorithm and an empirical binding free energy function. J Comp Chem 19:1639\u20131662","journal-title":"J Comp Chem"},{"key":"10551_CR100","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717. https:\/\/doi.org\/10.1038\/srep42717","journal-title":"Sci Rep"},{"key":"10551_CR101","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1023\/A:1020444330011","volume":"19","author":"YH Zhao","year":"2002","unstructured":"Zhao YH, Abraham MH, Le J, Hersey A, Luscombe CN, Beck G, Sherborne B, Cooper I (2002) Rate-limited steps of human oral absorption and QSAR studies. Pharm Res 19:1446\u20131457","journal-title":"Pharm Res"},{"key":"10551_CR102","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1021\/ci500588j","volume":"55","author":"T Sander","year":"2015","unstructured":"Sander T, Freyss J, von Korff M, Rufener C (2015) DataWarrior: an open-source program for chemistry aware data visualization and analysis. J Chem Inf Model 55:460\u2013473. https:\/\/doi.org\/10.1021\/ci500588j","journal-title":"J Chem Inf Model"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-022-10551-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-022-10551-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-022-10551-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T12:40:11Z","timestamp":1695645611000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-022-10551-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,4]]},"references-count":102,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10551"],"URL":"https:\/\/doi.org\/10.1007\/s11030-022-10551-0","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,4]]},"assertion":[{"value":"10 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}